Predicting EF trajectory phenotypes may inform the treatment of AML in pediatric patients
New research suggests that accurately predicting ejection fraction (EF) trajectory phenotypes can inform the personalization of prognosis and treatment for children with acute myeloid leukemia (AML). Study group-based trajectory methods identified distinct EF trajectory phenotypes with differential event-free survival and overall survival for each group. “Predictive models focused on trajectory-defined phenotypes can elucidate the genomic …